Abstract
Cardiovascular disease and dementia are common in the elderly and are major causes of disability in the general population. The public health burden of dementia is projected to increase as life expectancy increases in the United States and elsewhere. Epidemiological studies suggest that these once believed unrelated conditions, heart disease and dementia, may be linked by shared common risks and pathogenic elements. These observations have sparked the notion that prevention or modification of certain vascular risk factors and proper management of cardiovascular disease may prevent the development or progression of dementia including Alzheimer’s disease. In this article, the authors discuss the association between cognitive impairment and atrial fibrillation, coronary artery disease, congestive heart failure, and cardiovascular procedures.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci. 2010;1207:155–62.
•• Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713. This is an extensive overview on the vascular contributions to cognitive decline and serves as a guide for clinicians to understand the vascular cognitive impairment and dementia, its prevention and treatment.
Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, et al. Stroke: working toward a prioritized world agenda. Stroke. 2010;41:1084–99.
Haeusler KG, Laufs U, Endres M. Chronic heart failure and ischemic stroke. Stroke. 2011;42:2977–82.
Marshall RS, Lazar RM. Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke. 2011;42:221–6.
Festa JR, Jia Z, Cheung K, Marchidann A, Schmidt M, Shapiro PA, et al. Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol. 2011;68:1021–6.
English JD. Stroke as a complication of acute cardiac disease. Am Acad Neurol Continuum Lifelong Learn Neurol. 2011;17:1024–39.
•• Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 1995;274:1846–51. A landmark study reporting an association between midlife systolic blood pressure and late life cognitive function in Japanese-American men utilizing data from the Honolulu Heart Program (HHP) established in 1965 from examination of 8006 individuals from 1900–1991. The results showed that midlife systolic blood pressure is a significant predictor of reduced cognitive function in later life.
Alonso A, Mosley TH, Gottesman R, Catellier D, Sharett AR, Coresh J. Risk of dementia hospitalization associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) Study. J Neurol Neurosurg Psychiatry. 2009;80:1194–201.
Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35:2620–2.
Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, et al. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension. 2012;59:780–6.
Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842–52.
Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484–91.
Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Apolipoprotein ε4 allele elevated midlife total cholesterol level, and high midlife systolic blood pressures are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137:49.
• Reiss AB, Voloshyna I. Regulation of cerebral cholesterol metabolism in Alzheimer disease. J Investig Med. 2012;60:576–82. This article summarizes the current knowledge of the influence of cholesterol and lipid pathways in Alzheimer’s disease pathogenesis.
Kuller LH, Lopezb OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:13–22.
Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, et al. Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol. 2011;258:1295–303.
McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;4:CD004034.
Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. doi:10.1016/j.jalz.2011.05.2414
Ancelin ML, Carrière I, Barberger-Gateau P, Auriacombe S, Rouaud O, Fourlanos S, et al. Lipid lowering agents, cognitive decline, and dementia: The Three-City Study. J Alzheimers Dis. 2012;30:629–33.
Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141:137–47.
Bennet AM, Di AE, Ye Z, Wensley F, Dahlin A, Ahlbam A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298:1300–11.
Elosua R, Ordovas JM, Cupples LA, Fox CS, Polak JF, Wolf PA, et al. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res. 2004;45:1868–75.
Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349:151–4.
• Kwok CS, Loke YK, Hale R, Porter JF, Myint PK. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76:914–22. A detailed review discussing the relationship and pathophysiology of atrial fibrillation and cognitive dysfunction.
Laurin D, Masaki KH, White LR, Launer LJ. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation. 2007;116:2269–74.
Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53:1101–7.
Hong SW, Shim JK, Choi YS, Kim DH, Chang BC, Kwak YC. Prediction of cognitive dysfunction and patients' outcome following valvular heart surgery and the role of cerebral oximetry. Eur J Cardiothorac Surg. 2008;33:560–5.
Bucerius J, Gummert JF, Borger MA, Walther T, Doll N, Onnasch JF, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg. 2003;75:472–8.
Knipp SC, Matatko N, Schlamann M, Wilhem H, Thielmann M, Forsting M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg. 2005;28:88–96.
Braekken SK, Reinvang I, Russell D, Brucher R, Svennevig JL. Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J Neurol Neurosurg Psychiatry. 1998;65:573–6.
Guerrieri Wolf L, Choudhary BP, Abu-Omar Y, Taggart DP. Solid and gaseous cerebral microembolization after biologic and mechanical aortic valve replacement: investigation with multirange and multifrequency transcranial Doppler ultrasound. J Thorac Cardiovasc Surg. 2008;135:512–20.
• Kim IC, Hur SH, Park NH, Jun DH, Cho YK, Nam CW, et al. Incidence and predictors of silent embolic cerebral infarction following diagnostic coronary angiography. Int J Cardiol. 2011;148:179–82. An interesting study evaluating the incidence and predictors of silent cerebral infarcts following diagnostic coronary angiography.
Büsing KA, Schulte-Sasse C, Flüchter S, Suselbeck T, Haase KK, Neff W, et al. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging. Radiology. 2005;235:177–83.
Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomized study. Lancet. 2003;361:1241–6.
Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;12:1870–8.
Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427–32.
Astarci P, Glineur D, Kefer J, D'Hoore W, Renkin J, Vanoverschelde JL, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg. 2011;40:475–9.
Hamon M, Burzotta F, Oppenheim C, Morello R, Viader F, Hamon M. Silent cerebral infarct after cardiac catheterization as detected by diffusion weighted Magnetic Resonance Imaging: a randomized comparison of radial and femoral arterial approaches. Trials. 2007;8:15.
Caplan LR. Translating what is known about neurological complications of coronary artery bypass graft surgery into action. Arch Neurol. 2009;66:1062–4.
Likosky DS, Marrin CAS, Caplan LR, Baribeau YR, Morton JR, Weintraub RM, et al. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke. 2003;34:2830–4.
Wityk RJ, Restrepo L. Cardiac surgery and magnetic resonance imaging of the brain. Arch Neurol. 2002;59:1074–6.
Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol. 1990;28:477–86.
Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke. 2000;31:707–13.
Deklunder G, Roussel M, Lecroart J-L, Prat A, Gautier C. Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves. Stroke. 1998;29:1821–6.
Bendszuz M, Reents W, Franke D, Mullges W, Babin-Ebell J, Koltzenburg M, et al. Brain damage after coronary artery bypass grafting. Arch Neurol. 2002;59:1090–5.
McKhann GM, Grega MA, Borowicz LM, Baumgartner WA, Selnes OA. Stroke and encephalopathy after cardiac surgery: an update. Stroke. 2006;37:562–71.
Gottesman RF, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, et al. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol. 2010;67:338–44.
Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephius JC, van Boven WJ, et al. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med. 2003;348:394–402.
Restrepo L, Wityk RJ, Grega MA, Borowicz L Jr, Barker PB, Jacobs MA, et al. Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke. 2002;33:2909–15.
Barber PA, Hach S, Tippett LJ, Ross L, Merry AF, Milsom P. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008;39:1427–33.
Gottesman RF, Hillis AE, Grega M, Borowicz LM Jr, Selnes OA, Baumgartner WA, et al. Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol. 2007;64:1111–4.
Koenig MA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, et al. Statin use and neurological morbidity after coronary artery bypass grafting. Neurology. 2009;73:2099–106.
Li Y, Walicki D, Mathiesen C, Jenny D, Li Q, Isayev Y, et al. Strokes after cardiac surgery and relationship to carotid stenosis. Arch Neurol. 2009;66:1091–6.
Cebelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of interleukin-1B in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360–8.
Rodriguez RA, Rubens FD, Wozny D, Nathan HJ. Cerebral embolic detected by transcranial Doppler during cardiopulmonary bypass are not correlated with postoperative cognitive deficits. Stroke. 2010;41:2229–35.
Selnes OA, Royall RM, Grega MA, Borowicz LM Jr, Quaskey S, Mc Khann GM. Cognitive changes 5 years after coronary artery bypass grafting. Is there evidence of late decline? Arch Neurol. 2001;58:598–604.
Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, et al. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001;32:2874–81.
Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395–402.
Selnes OA, McKhann G. Late cognitive decline after CABG. Inevitable or preventable? Neurology. 2002;59:660–1.
Gorelick PB, Bowler JV. Advances in vascular cognitive impairment. Stroke. 2010;41:93–8.
Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, et al. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol. 2008;63:581–90.
Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, et al. Do management strategies for coronary artery disease influence 6-year cognitive outcomes? Ann Thorac Surg. 2009;344:395–402.
Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, et al. On-pump vs off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361:1827–37.
Van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EW, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007;297:701–8.
Sedrakyan A, Wu AW, Parashar A, Bass EB, Treasure T. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity compared with traditional coronary artery bypass grafting. A meta-analysis of systemically reviewed trials. Stroke. 2006;37:2759–69.
Mathew JP, Grocott HP, Phillips-Bute B, Stafford-Smith M, Laskowitz DT, Rossignol D, et al. Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke. 2003;34:508–13.
Mathew JP, Rinder HM, Smith BR, Newman MF, Rinder CS. Transcranial platelet activation after aortic cross-clamp release is linked to neurocognitive decline. Ann Thorac Surg. 2006;81:1644–9.
Grocott HP, White WD, Morris RW, Podgoreanu MV, Mathew JP, Nielsen DM, et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke. 2005;36:1854–8.
Mathew JP, Mackensen GB, Phillips-Bute B, Grocott HP, Glower DD, Laskowitz DT, et al. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke. 2009;40:880–7.
Ti LK, Mathew JP, Mackensen GB, Grocott HP, White WD, Reves JG. Effect of apolipoprotein E genotype on cerebral autoregulation during cardiopulmonary bypass. Stroke. 2001;32:1514–9.
Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA. Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. Neurology. 2005;65:986–90.
Potter GG, Plassman BL, Helms MJ, Steffens DC, Welsh-Bohmer KA. Age effects of coronary artery bypass graft on cognitive status change among elderly male twins. Neurology. 2004;63:2245–9.
•• Newman MF, Mathew JP, Grocott HP, Mackensen GB, Monk T, Welsh-Bohmer KA, et al. Central nervous system injury associated with cardiac surgery. Lancet. 2006;368:694–703. A literature review on the neurological complications following cardiac surgery including the incidence and causes of neurocognitive dysfunction.
Selnes OA, McKhann GM. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol. 2005;57:615–21.
Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, Seshadri S, et al. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation. 2010;122:690–7.
Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, et al. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc. 1998;46:1343–8.
Sauvé MJ, Lewis WR, Blankenbiller M, Rickabaugh B, Pressler SJ. Cognitive impairments in chronic heart failure: a case controlled study. J Card Fail. 2009;15:1–10.
Vogels RL, Scheltens P, Schroeder-Tank JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9:440–9.
Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging. 2007;28:477–83.
Trojano L, Antonelli Incalzi R, Acanfora D, Picone C, Mecocci P, Rengo F. Cognitive impairment: a key feature of congestive heart failure in the elderly. J Neurol. 2003;250:1456–63.
Georgiadis E, Sievert M, Cencetti S, Uhlmann F, Krivokuca M, Zierz S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J. 2000;21:407–13.
Pullicino P, Mifsud V, Wong E, Graham S, Ali I, Smajlovic D. Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis. 2001;10:178–82.
Jefferson AL. Cardiac output as a potential risk factor for abnormal brain aging. Alzheimers Dis. 2010;20:813–21.
de la Torre JC. Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis. 2008;5:126–32.
Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke. 2001;32:2530–3.
Koide H, Kobayashi S, Kitani M, Tsunematsu T, Nakazawa Y. Improvement of cerebral blood flow and cognitive function following pacemaker implantation in patients with bradycardia. Gerontology. 1994;40:279–85.
Conti JB, Sears SF. Cardiac resynchronization therapy: can we make our heart failure patients smarter? Trans Am Clin Climatol Assoc. 2007;118:153–64.
Pullicino PM, Wadley VG, McClure LA, Safford MM, Lazar RM, Klapholz M, et al. Factors contributing to global cognitive impairment in heart failure: results from a population based cohort. J Card Fail. 2008;14:290–5.
Zuccala G, Onder G, Marzetti E, Monaco MR, Cesari M, Cocchi A, et al. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J. 2005;26:226–33.
Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316–21.
Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59:1369–75.
Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012;184:329–36.
Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Hear Rhythm. 2010;7:433–7.
Knecht S, Oelschläger C, Duning T, Lohmann H, Albers J, Stehling C, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J. 2008;29:2125–32.
Kilander, Andren B, Nyman H, Lind L, Boberg M, Lithell H. Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men. Stroke. 1998;29:1816–20.
Efimova I, Efimova N, Chernov V, Popov S, Lishmanov Y. Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates. Pacing Clin Electrophysiol. 2012;35:320–6.
Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:839–45.
Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, et al. Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE) Investigators. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010;3:277–83.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muqtadar, H., Testai, F.D. & Gorelick, P.B. The Dementia of Cardiac Disease. Curr Cardiol Rep 14, 732–740 (2012). https://doi.org/10.1007/s11886-012-0304-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-012-0304-8